These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13719950)

  • 21. [Blood iron and copper in hepatobiliary disease].
    BUTZENGEIGER KH; LANGE J
    Dtsch Arch Klin Med; 1952; 199(5-6):633-47. PubMed ID: 13033529
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of the antitoxic principle upon hepatobiliary diseases.
    NASIO J
    Rev Gastroenterol; 1948 Dec; 15(12):877-910. PubMed ID: 18893699
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of serum leucine aminopeptidase, phosphohexoisomerase and isocitric dehydrogenase in hepatobiliary pathology].
    VACCA G; FERRO GF; PIASCO D
    Minerva Med; 1962 Jun; 53():1933-7. PubMed ID: 13924077
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renal manifestations during hepatobiliary diseases. I].
    PLAUCHU ; MORNEX ; BURLET P
    Lyon Med; 1956 Jan; 88(1):2-21; contd. PubMed ID: 13308240
    [No Abstract]   [Full Text] [Related]  

  • 25. [Renal manifestations during hepatobiliary diseases. II].
    PLAUCHU ; MORNEX ; BURLET P
    Lyon Med; 1956 Jan; 88(2):29-40; contd. PubMed ID: 13308241
    [No Abstract]   [Full Text] [Related]  

  • 26. [Renal manifestations during hepatobiliary diseases. III].
    PLAUCHU ; MORNEX ; BURLET P
    Lyon Med; 1956 Jan; 88(3):53-69; concl. PubMed ID: 13308242
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal function in hepatobiliary diseases].
    CAVAZZUTI F; PETRIN G; ZOBOLI P
    Arch Patol Clin Med; 1952; 30(4):227-38. PubMed ID: 13031842
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical significance of serum leucine aminopeptidase in hepatobiliary and pancreatic diseases].
    TAKAOKA Y; TAKAMORI M
    Nisshin Igaku Jpn J Med Prog; 1962 Feb; 49():82-96. PubMed ID: 13919139
    [No Abstract]   [Full Text] [Related]  

  • 29. [Xanthomatosis and hepatobiliary diseases].
    JOSEPHSEN JO
    Nord Med; 1956 Jan; 55(3):77-81. PubMed ID: 13288881
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes of serum lipoproteins in patients with diseases of the liver, biliary tract and blood].
    WANG C
    Ter Arkh; 1960 Jun; 32():58-62. PubMed ID: 13783029
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative investigations on the activity of leucine aminopeptidase, glutamic oxalacetic transaminase. and alkaline phosphatase in serum.
    MUNCK BG; KJERULF K
    Gut; 1961 Sep; 2(3):225-9. PubMed ID: 14477184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alkaline serum phosphatase in diseases of the liver and biliary tract].
    EGGHART F
    Wien Z Inn Med; 1957 Dec; 38(12):518-23. PubMed ID: 13531122
    [No Abstract]   [Full Text] [Related]  

  • 33. [1-131 rose bengal test of hepatobiliary diseases].
    ANASAWA Y; HIRANO S; NAKAHARA E
    Rinsho Geka; 1962 Apr; 17():261-9. PubMed ID: 13861098
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholecystography and cholangiography: comparative study of various methods and their relative diagnostice value in hepatobiliary disease.
    STEGILICH CP; PERLBERG HJ
    Am J Dig Dis; 1957 Feb; 2(2):50-67. PubMed ID: 13402731
    [No Abstract]   [Full Text] [Related]  

  • 35. [The thrombelastogram in diseases of the liver and biliary tract].
    BROICHER H; EGLI H
    Dtsch Med Wochenschr; 1961 Dec; 86():2540-2. PubMed ID: 13873374
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lipoproteins in liver & biliary tract diseases].
    SZERESZEWSKA H; CHODERA L; PATELSKI J
    Pol Arch Med Wewn; 1957; 27(11):1511-24. PubMed ID: 13527287
    [No Abstract]   [Full Text] [Related]  

  • 37. The serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease.
    CAREY JB
    J Clin Invest; 1958 Nov; 37(11):1494-503. PubMed ID: 13587658
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum glutamic oxaloacetic transaminase activity and serum glutamic pyruvic transaminase activity in liver diseases.
    VANIKAR VA; BHATT JT
    Indian J Med Sci; 1960 Apr; 14():344-50. PubMed ID: 13841248
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum cholinesterase and liver diseases].
    MAIER EH
    Dtsch Med Wochenschr; 1956 Oct; 81(42):1674-8. PubMed ID: 13375267
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of liver damage on serum glutamic oxalacetic transaminase and glutamic pyruvic transaminase.
    RANGAM CM; SHRIVASTAVA KK; GUPTA JC
    J Indian Med Assoc; 1962 Apr; 38():395-9. PubMed ID: 14490264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.